![Lucio Iannone](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Lucio Iannone
Directeur/Membre du Conseil chez
eGenesis, Inc.
Profil
Lucio Iannone is currently Director at Axxam SpA, eGenesis, Inc., Khloris Biosciences, Inc., Immunitas Therapeutics, Inc., Kojin Therapeutics, Inc., Vesigen, Inc., Paratus Sciences Corp., and Mozart Therapeutics, Inc. He is Managing Director at A Breakthrough T1D Venture LLC starting in 2025.
He holds the positions of Vice President of Venture Investments and Vice President at Leaps By Bayer since 2021.
Former roles include Director at Azitra, Inc., GRO Biosciences, Inc., and Pyxis Oncology, Inc. from 2019 to 2021.
He was Head of Business Development at Silence Therapeutics Plc from 2015 to 2017.
Education includes a doctorate from Imperial College London, a graduate degree from the University of Cambridge conferred in 2008, and an undergraduate degree from Università degli Studi di Napoli Federico II conferred in 2006.
Postes actifs de Lucio Iannone
| Sociétés | Poste | Début |
|---|---|---|
Immunitas Therapeutics, Inc.
 Immunitas Therapeutics, Inc. BiotechnologyHealth Technology Develops single cell genomic-based drugs | Directeur/Membre du Conseil | 01/11/2019 |
eGenesis, Inc.
 eGenesis, Inc. Medical/Nursing ServicesHealth Services Operates as a biotechnology company that provides organs and cells transplantation services | Directeur/Membre du Conseil | 01/11/2019 |
Vesigen, Inc.
 Vesigen, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Directeur/Membre du Conseil | 01/12/2020 |
Khloris Biosciences, Inc.
 Khloris Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as biotechnology company | Directeur/Membre du Conseil | 01/12/2018 |
Axxam SpA
 Axxam SpA Miscellaneous Commercial ServicesCommercial Services Operates as a research organization in life science industry | Directeur/Membre du Conseil | 01/05/2019 |
Kojin Therapeutics, Inc.
 Kojin Therapeutics, Inc. BiotechnologyHealth Technology Operates as a small-molecule therapeutics company which develops therapeutics for cancer, fibrosis, ischemia and immune modulation | Directeur/Membre du Conseil | - |
Leaps By Bayer /US/
 Leaps By Bayer /US/ Investment ManagersFinance Functions as an alternative investment manager | Private Equity Investor | 01/10/2017 |
Mozart Therapeutics, Inc.
 Mozart Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapies to cure autoimmune diseases | Directeur/Membre du Conseil | 01/03/2021 |
Paratus Sciences Corp.
 Paratus Sciences Corp. BiotechnologyHealth Technology Operates as a biotechnology company | Directeur/Membre du Conseil | - |
| ░░░░░ ░░ ░░░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
Anciens postes connus de Lucio Iannone
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Formation de Lucio Iannone
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
71
Relations au 1er degré
18
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 18 |
|---|---|
Silence Therapeutics Plc
 Silence Therapeutics Plc Miscellaneous Commercial ServicesCommercial Services Engages in the research and development of novel pharmaceutical products | Commercial Services |
Imperial College London
 Imperial College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Axxam SpA
Axxam SpA Miscellaneous Commercial ServicesCommercial Services Operates as a research organization in life science industry | Commercial Services |
Università degli Studi di Napoli Federico II
 Università degli Studi di Napoli Federico II Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
eGenesis, Inc.
eGenesis, Inc. Medical/Nursing ServicesHealth Services Operates as a biotechnology company that provides organs and cells transplantation services | Health Services |
Azitra, Inc.
 Azitra, Inc. Pharmaceuticals: MajorHealth Technology Operates as an clinical biopharmaceutical company that develops and commercializes therapies for precision dermatology | Health Technology |
GRO Biosciences, Inc.
 GRO Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops protein-based therapies | Health Technology |
JDRF T1D Fund
 JDRF T1D Fund Investment ManagersFinance T1D Fund invests in companies located across the globe. The firm focuses on health technology sector. It participates in early stage capital requirements. | Finance |
Khloris Biosciences, Inc.
Khloris Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as biotechnology company | Commercial Services |
Leaps by Bayer
 Leaps by Bayer Investment ManagersFinance Leaps by Bayer invests in companies located in the United States and Germany. The firm targets companies operating in the fields of healthcare and agriculture sectors. It provides financing for early stage capital requirements. | Finance |
Pyxis Oncology, Inc.
 Pyxis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a preclinical oncology company focused on developing an arsenal of next-generation therapeutics | Health Technology |
Immunitas Therapeutics, Inc.
Immunitas Therapeutics, Inc. BiotechnologyHealth Technology Develops single cell genomic-based drugs | Health Technology |
Kojin Therapeutics, Inc.
Kojin Therapeutics, Inc. BiotechnologyHealth Technology Operates as a small-molecule therapeutics company which develops therapeutics for cancer, fibrosis, ischemia and immune modulation | Health Technology |
Vesigen, Inc.
Vesigen, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Mozart Therapeutics, Inc.
Mozart Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapies to cure autoimmune diseases | Health Technology |
Leaps By Bayer /US/
Leaps By Bayer /US/ Investment ManagersFinance Functions as an alternative investment manager | Finance |
Paratus Sciences Corp.
Paratus Sciences Corp. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
